SOMA stands as an ingenious research automation platform, meticulously crafted to catapult the realm of medical innovation to new heights. Its core functionality revolves around the thorough analysis of publicly available medical research articles, adeptly extracting pivotal concepts and unraveling causal and associative relationships that interweave them.
The wealth of extracted insights is systematically cataloged within a specialized database, aptly known as a knowledge graph. This serves as a dynamic resource for researchers, who can input specific pairs of concepts, prompting the system to retrieve highly pertinent causal chains of customizable lengths.
Not content with merely organizing information, SOMA elevates the process of literature reviews by skillfully identifying articles that align with the researcher’s predefined cause-and-effect relationships. It excels in capturing documents based on the intricate mechanisms of action, thereby unveiling hidden connections and invaluable context. This ingenious feature liberates researchers from the burdensome task of organizing reviews, allowing them to channel their energies and intellect into their core research endeavors.
SOMA harbors an ambitious goal: to streamline research workflows and reclaim up to a staggering 80% of the time typically consumed by document pre-processing. By seamlessly automating the analysis of previously published research, it ushers in a new era of research efficacy, enriching the knowledge base and propelling scientific exploration.
To welcome users into its world of innovation, the platform extends a gracious free trial period spanning 14 days, granting unrestricted access to its suite of formidable features. Access to this trial can be effortlessly secured through the platform’s website, or users may opt to engage directly with the SOMA team for comprehensive information and guidance.
SOMA, the brainchild of Cloudcell Limited, proudly constitutes an integral part of the prestigious Systematic Objective Meta Analysis (SOMA) project, further underscoring its commitment to shaping the future of medical research.